Panion & Bf Biotech Inc. (TPE:1760)

Panion & Bf Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	213.71	190.17	124.52	77.22	182.35	104.4
Depreciation & Amortization	137.84	138.42	164.42	170.39	163.55	143.62
Loss (Gain) From Sale of Assets	0.13	0.13	0.1	0.38	-6.28	0.44
Loss (Gain) From Sale of Investments	-0.37	-0.24	-1.46	-7.5	93.68	-6.72
Loss (Gain) on Equity Investments	-2.44	-2.65	8.44	14.02	8.18	12.17
Stock-Based Compensation	-	-	-	-	-	11.72
Provision & Write-off of Bad Debts	1.42	0.85	-0.33	-1.05	0.08	2.09
Other Operating Activities	-14.78	-14.84	-16.02	-27.98	44.15	8.81
Change in Accounts Receivable	-29.22	1.08	4.72	1.31	-9.7	23.61
Change in Inventory	-23.9	-41.95	12.62	7.12	-15.88	32.33
Change in Accounts Payable	2.18	9.27	19.8	8.21	-5.69	-31.94
Change in Other Net Operating Assets	46.89	29.34	34.37	-64.69	65.4	69.98
Operating Cash Flow	331.45	309.57	351.19	177.42	489.87	401.23
Operating Cash Flow Growth	2.44%	-11.85%	97.94%	-63.78%	22.09%	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-142.93	-148.34	-185.69	-181.23	-198.64	-170.01
Sale of Property, Plant & Equipment	-	-	0.11	0.01	24.72	-
Sale (Purchase) of Intangibles	-10	-10	-	-	-	-
Investment in Securities	6.52	27.87	13.19	15.05	15	-43.01
Other Investing Activities	2	1.29	13.62	10.9	14.46	-2.03
Investing Cash Flow	-144.41	-129.18	-158.77	-155.27	-144.47	-215.05

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	920	1,205	1,305	1,705	1,931
Long-Term Debt Issued	-	35	59.24	117.86	22.9	54.38
Total Debt Issued	965	955	1,264	1,423	1,728	1,985
Short-Term Debt Repaid	-	-1,000	-1,240	-1,165	-1,575	-2,131
Long-Term Debt Repaid	-	-63.29	-45.41	-31.12	-181.61	-634.13
Total Debt Repaid	-1,036	-1,063	-1,285	-1,196	-1,757	-2,765
Net Debt Issued (Repaid)	-70.94	-108.29	-21.17	226.74	-28.71	-779.75
Issuance of Common Stock	-	-	-	-	-	628.43
Common Dividends Paid	-154.33	-154.33	-128.61	-171.48	-128.61	-53.72
Other Financing Activities	-15.07	-15.29	-20.73	-6.6	-10.07	-12.72
Financing Cash Flow	-240.34	-277.9	-170.51	48.67	-167.39	-217.76

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.16	-0.54	1.84	-0.44	7.14	0.58
Net Cash Flow	-53.46	-98.06	23.75	70.37	185.15	-31.01

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	188.52	161.23	165.49	-3.81	291.23	231.22
Free Cash Flow Growth	12.13%	-2.57%	-	-	25.95%	-
Free Cash Flow Margin	8.97%	7.81%	8.15%	-0.20%	12.14%	12.16%
Free Cash Flow Per Share	2.19	1.88	1.93	-0.04	3.39	2.92
Levered Free Cash Flow	190.7	153.1	93.15	46.79	300.67	187.8
Unlevered Free Cash Flow	199.53	162.07	102.54	53.89	305.41	196.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	14.75	15.05	14.61	11.08	7.64	14.7
Cash Income Tax Paid	131.34	128.76	122.64	119.05	109.11	76.91
Change in Working Capital	-4.06	-2.27	71.51	-48.06	4.17	124.7

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error